Essential Reads: What is the Best Screening Tool for Depression During Pregnancy?
Many women experience depression during pregnancy. What is the best way to identify these women?
Many women experience depression during pregnancy. What is the best way to identify these women?
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on practicing perinatal psychiatry during the ongoing COVID-19 pandemic with Ob.Gyn News on November [...]
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.
To address the growing demand for specialized knowledge in perinatal psychiatry, the Center for Women's Mental Health is pleased to announce its newest CME course offering: Perinatal Psychiatry: In Depth Modules for Enhanced Approaches. [...]
As our faculty at the Center for Women’s Mental Health (CWMH) have gone fully remote with respect to clinical and research activity, we have managed to stay connected these last three weeks with “virtual rounds”. [...]
As our faculty at the Center for Women’s Mental Health (CWMH) have gone fully remote with respect to clinical and research activity, we have managed to stay connected these last three weeks with “virtual rounds”. [...]
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, [...]
When we started our website 15 years ago, a productive month in the field of reproductive psychiatry meant that a few good articles were published. Times have certainly changed. In fact, it is sometimes difficult [...]
We would like to thank you for your continuing support of the National Pregnancy Registry for Atypical Antipsychotics (NPRAA) at the Center for Women’s Mental Health at Massachusetts General Hospital. We are grateful for all the referrals made to the Registry as our numbers continue to grow every day. Given the Registry’s successful enrollment, we are pleased to announce our plan to release preliminary data at an upcoming conference in June, the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.